Trial intelligence / Profile preview

Amniotic Fluid vs Corticosteroid for Knee Osteoarthritis

NCT04886960Phase 2Completed

Sponsor
University of Utah
Start
Jul 2021
Primary completion
Jan 2025
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in osteoarthritis (OA) (2 arms), sponsored by University of Utah. Primary endpoint: Repeat Allogeneic Intra-articular Injection at 6 months. Started Jul 2021; status: completed.

02

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04886960.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04886960.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call